Related Experiment Videos
[Gene therapy in autoimmune rheumatic diseases]
I Sekigawa1, H Ogasawara, S Hirose
1Department of Medicine, Juntendo University Izu-Nagaoka Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 17, 1999
Summary
Gene therapy shows promise for experimental autoimmune diseases like diabetes and arthritis. This review explores its potential as a novel treatment strategy for human autoimmune rheumatic disorders.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Context:
- Autoimmune diseases, including type-1 insulin-dependent diabetes (IDDM), experimental allergic encephalomyelitis (EAE), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE), pose significant challenges.
- Current therapeutic strategies for many autoimmune conditions remain limited, necessitating novel approaches.
Purpose:
- To review existing research on gene therapy for experimental autoimmune diseases in animal models.
- To discuss the feasibility and potential of gene therapy as a new therapeutic strategy for human autoimmune rheumatic disorders, specifically RA and SLE.
Summary:
- Investigated the application of gene therapy in preclinical models of autoimmune diseases such as IDDM, EAE, RA, and SLE.
- While direct human trials for rheumatic autoimmune diseases are absent, the review synthesizes findings from animal studies.
- Highlights the potential of gene therapy to address the underlying mechanisms of autoimmune rheumatic disorders.
Impact:
- Provides a comprehensive overview of gene therapy's current status in autoimmune disease research.
- Suggests a potential paradigm shift in treating human autoimmune rheumatic diseases like RA and SLE.
- Lays the groundwork for future research and clinical translation of gene-based therapies for autoimmune conditions.